Effect of combination therapy on adherence among US patients

31 January 2017

New trial evidence suggests that many patients may require more aggressive pharmacologic management to achieve lower blood pressure goals. Especially when first initiating anti-hypertensive treatment, it is unknown whether starting patients on multiple medications may be better for long-term adherence and persistence compared with starting one medication.
The objective of the study was to examine contemporary patterns of anti-hypertensive therapy initiation and compare long-term adherence and persistence among patients initiating fixed-dose combinations and single anti-hypertensive therapies. An article about the research was published in the Journal of General Internal Medicine.
Click here for the full article about the research.
Click here for more information about the NVC project Pharmaceutical Packaging Innovation.
Click here for more information about the NVC E-Course Pharmaceutical Packaging.

This news item is also included in our monthly overview, the NVC Members-only Update. If you have any questions, please contact us: info@nvc.nl, +31-(0)182-512411.